Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity was posted on January 19, 2016. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

SuperScript II One-Step RT-PCR - Brand Name or Equal

Closed
W81XWH-16-T-0031Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

Contract Value

$16,320

NAICS

325199 - All Other Basic Organic Chemical Manufacturing

Place of Performance

US Army Medical Research Institute of Infectious Diseases 1425 Porter Street Fort Detrick, MD 21702-9211, Fort Detrick, MD, 21702, USA

Set-Aside

SBA

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts

Full Description

Show more
1. INSTRUCTIONS FOR THE PREPARATION AND SUBMISSION OF QUOTES Failure to submit all documents concurrently and in accordance with these instructions may render a quote unacceptable. The quote and supporting documentation shall be submitted electronically via email to the Contract Specialist, Mr. Abraham Pottenger at abraham.g.pottenger.civ@mail.mil by the date and time specified on the SF-1449, Block #8. 2. QUOTE AND SUPPORTING DOCUMENTATION EVALUATION To aid in evaluation, the Offeror's quote shall be practical, specific complete, and logically assembled. The Offeror's quote shall be in a clear, concise format and detailed to demonstrate the Offeror is capable of satisfying the requirement in accordance with this Request for Quote (RFQ). The Offeror's quote shall be valid for 90 days. 2.1. The Offeror's quote shall provide the make and model of the product(s), manufacturer sales literature or other product literature which clearly documents the offered brand name or equal product(s) that meet or exceed the Minimal Essential Characteristics (MECs) identified in Table 1 of this RFQ. 2.2 Offerors offering "equal" product(s) shall provide a matrix which correlates to the MECs identified in Table 1 of this RFQ. 3. QUESTIONS Questions concerning this RFQ are due no later than 11:00 AM EST on 21 January 2016. Questions shall be submitted to the Contract Specialist, Mr. Abraham Pottenger at abraham.g.pottenger.civ@mail.mil. The Government will accept only one set of questions per Offeror and questions not submitted electronically via email to the Contract Specialist will not be answered. Answers to the Offerror's questions shall be addressed via an amendment to this RFQ. In the event multiple questions address the same issue, the Government reserves the right to answer a representative question that best exemplifies the issue. No questions will be accepted or addressed after the cutoff date and time listed above 1. Must be a single-tube kit - meaning that both the Reverse Transcription (RT) reaction and the amplification must capable to be done in the same tube. 2. Must be a mix containing both the reverse transcriptase and Platinum taq DNA polymerase. 3. Must be capable of amplifying by RT-PCR targets of up to 3 kb. 4. Must be compatible with real-time PCR assays including SYBR Green and TaqMan. 5. RT must be active at a temperature of 50'C for at least 15 minutes for conformity with existing, validated assays and instruments. 6. RT must be inactivated at 94'C for conformity with existing, validated assays and instruments. 7. Must have minimal lot-to-lot variability compared to existing SuperScript II One-Step RT-PCR with Platinum Taq DNA polymerase lots for conformity with existing, validated assays and instruments. See solicitation for full listing of requirement. Please be sure to fill out DFARS 252.209-7999 (DEV).

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS